Overview
The chemical compound calcium acetate is the calcium salt of acetic acid. It has been commonly referred to as the acetate of lime. The anhydrous form is very hygroscopic, therefore the monohydrate is the common form.
Indication
Calcium acetate is one of a number of calcium salts used to treat hyperphosphatemia (too much phosphate in the blood) in patients with kidney disease.
Associated Conditions
- Hyperphosphataemia
- High phosphate levels
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2020/03/09 | Phase 1 | Completed | |||
2013/11/25 | Early Phase 1 | Completed | |||
2011/01/17 | Phase 4 | Terminated | |||
2010/06/03 | Phase 4 | Completed | Gulhane School of Medicine | ||
2008/11/05 | Not Applicable | Completed | |||
2006/08/15 | Not Applicable | Withdrawn | Romanian Society of Nephrology | ||
2005/09/21 | Phase 4 | Completed | |||
2005/09/21 | Phase 3 | Completed | |||
2001/07/05 | Not Applicable | Completed | National Center for Research Resources (NCRR) |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| Rising Pharma Holdings, Inc. | 16571-813 | ORAL | 667 mg in 1 1 | 10/19/2022 | |
| EXELAN PHARMACEUTICALS, INC. | 76282-377 | ORAL | 667 mg in 1 1 | 6/1/2021 | |
| Suven Pharmaceuticals Limited | 68022-0119 | ORAL | 667 mg in 1 1 | 1/9/2024 | |
| Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-621 | ORAL | 667 mg in 1 1 | 11/10/2021 | |
| LUPIN LIMITED | 57297-134 | ORAL | 667 mg in 1 1 | 2/17/2016 | |
| Carilion Materials Management | 68151-5204 | ORAL | 667 mg in 1 1 | 9/3/2015 | |
| State of Florida DOH Central Pharmacy | 53808-0216 | ORAL | 667 mg in 1 1 | 3/12/2010 | |
| State of Florida DOH Central Pharmacy | 53808-1001 | ORAL | 667 mg in 1 1 | 12/29/2014 | |
| Chartwell RX, LLC. | 62135-191 | ORAL | 667 mg in 1 1 | 10/3/2023 | |
| Physicians Total Care, Inc. | 54868-3460 | ORAL | 667 mg in 1 1 | 1/6/2011 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| Calcium Acetate Granules | 国药准字H53021733 | 化学药品 | 颗粒剂 | 5/27/2020 | |
| Calcium Acetate Granules | 国药准字H20193397 | 化学药品 | 颗粒剂 | 12/26/2019 | |
| Calcium Acetate Granules | 国药准字H20183325 | 化学药品 | 颗粒剂 | 7/31/2023 | |
| Calcium Acetate Granules | 国药准字H20193396 | 化学药品 | 颗粒剂 | 12/26/2019 | |
| Calcium Acetate Granules | 国药准字H53021640 | 化学药品 | 颗粒剂 | 5/27/2020 | |
| Calcium Acetate Granules | 国药准字H20183326 | 化学药品 | 颗粒剂 | 7/31/2023 | |
| Calcium Acetate Capsules | 国药准字H20100127 | 化学药品 | 胶囊剂 | 5/27/2020 | |
| Calcium Acetate Tablets | 国药准字H20223068 | 化学药品 | 片剂 | 1/30/2022 | |
| Calcium Acetate Tablets | 国药准字H20234168 | 化学药品 | 片剂 | 9/19/2023 | |
| Calcium Acetate Tablets | 培力药品工业股份有限公司 | 国药准字HC20210001 | 化学药品 | 片剂 | 4/7/2021 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.